How long does Wegovy take to start working — and what happens first?

The first injection arrives — and the wait begins

Picture the moment your pen turns up: a discreet plain box, DPD tracking confirming it at your door, the injector smaller and lighter than most people imagine. You give yourself the first 0.25mg dose and then (reasonably) wonder when something will happen.

The honest answer is that the earliest shifts are biochemical rather than visible. Semaglutide begins binding to GLP-1 receptors almost immediately after your injection, slowing how quickly your stomach empties and starting to influence the hunger signals your brain receives. Most people describe a subtle reduction in the urgency of hunger within the first week or two: smaller portions feel satisfying, the pull toward snacking between meals loosens a little.

What you will not see yet is significant weight loss. A week or two of reduced appetite accounts for a small shift at most. This is normal physiology, not a sign the medicine isn't working. The Wegovy dosing schedule starts at 0.25mg specifically to let your digestive system adjust with the least disruption, only once your prescriber moves you through successive dose levels does the appetite-suppressing effect reach its full strength.

If your experience in these early days includes nausea, queasiness after meals, or looser bowel habits, that too is expected. The NHS semaglutide medicines page notes these GI effects are among the most common and generally settle within days to a couple of weeks at each dose level.

Weeks four to twelve: when the scale starts to move

By the time your prescriber reviews whether to increase your dose (typically after four weeks at each level) most people have begun to see the first noticeable changes in body weight. This is where the treatment starts delivering what you came for, though the rate is gradual by design.

Hunger continues to reduce as the dose climbs. Gastric emptying slows further, which means meals feel substantial for longer. Many people also find their relationship with food shifting in ways that are harder to quantify: less preoccupation with what to eat next, a lower ceiling on how much feels comfortable. These changes compound over weeks rather than arriving all at once.

It is worth being clear about what the evidence actually shows. The STEP 1 trial, published in the New England Journal of Medicine, followed adults taking 2.4mg semaglutide weekly for 68 weeks alongside lifestyle support. The average weight reduction was around 15%. That figure spans the whole trial period, it is a destination, not a six-week result. Understanding when the effect typically kicks in helps set the right expectations from the start.

Individual variation matters here. Genetics, starting weight, diet, activity and how strictly the titration schedule is followed all influence how quickly results accumulate. A prescriber who knows your full picture is the right person to interpret what your progress means.

Why the maintenance dose changes things

The licensed maintenance dose for Wegovy injection is 2.4mg weekly, reached after a series of upward steps over roughly sixteen to twenty weeks. In April 2026 the MHRA also approved a higher 7.2mg dose in a dedicated single-dose pen, following trial data showing average weight loss of around 20.7% over 72 weeks, narrowing the gap with the highest-dose tirzepatide results. These figures, from the MHRA's approval announcement, reinforce that the timeline to maximum effect is measured in months, not days.

Once someone reaches and stays on their maintenance dose, weight loss tends to be most consistent. The appetite-regulatory effects are operating at their intended level, and many people find this the period where changes become visible to others around them. Plateaus can still occur; the prescriber's role through each stage of the journey includes reviewing whether continuing is appropriate and clinically warranted.

For context on how Wegovy's timeline compares with cost and access considerations, the weight-loss treatment overview covers what private treatment involves. Wegovy is a prescription-only medicine, a prescriber determines whether it is suitable for you after a clinical assessment, and the dosing schedule you follow is set by that clinical review, not by personal preference.

What slows progress, and what to do about it

A few practical things affect how quickly Wegovy starts working for any individual. Skipping doses interrupts the steady blood concentration the medicine depends on. Eating substantially more than appetite signals suggest, or not pairing treatment with any lifestyle changes, blunts the results the trials demonstrated. These are not judgements, they are mechanics, and they matter.

Side effects that make eating uncomfortable can paradoxically lead to poor nutritional choices (very small meals, limited protein) which affect body composition rather than just weight. Keeping protein intake adequate and staying hydrated is something our prescribers mention regularly in aftercare. If side effects feel unmanageable, the right step is to contact the prescriber, not to stop the medicine unilaterally.

If you have questions specific to your situation, the most common questions we receive cover a wide range of scenarios. And how Wegovy's early effects actually feel is a question worth exploring in its own right, and what Wegovy actually does as it starts working is something many people find helpful to understand before that first injection, the physical sensation of reduced hunger is different from what many people expect.

Ready to find out whether Wegovy is suitable for you? Check your eligibility with a free consultation, reviewed by a GPhC-registered prescriber, the same day.